At close: Feb 06, 16:00:00 GMT-5
Post-market: Feb 06, 20:00:00 GMT-5
No Data Yet
Hologic, Inc. secured FDA approval on February 4, 2026, for its Aptima® HPV Assay for primary cervical cancer screening, a decision supported by a real-world study involving over 650,000 women.
Medical device maker Hologic reported a 2.5% year-over-year revenue increase to $1.05 billion for its quarter ending December 2025, driven by mixed international performance that included a significant miss in Asia-Pacific sales.